CORONIL KIT
PATANJALI'S CLAIM ABOUT CRONIL
- A first clinical controlled study, which took place in Delhi, Ahmedabad, among many other cities. Under this 280 patients were included and 100 per cent of those recovered. We were able to control Corona and its complications in this. After this the all-important clinical control trial was conducted," Ramdev said.
- Patanjali collaborated with the privately-owned National Institute of Medical Sciences or NIMS University, Jaipur."With the help of NIMS, Jaipur we conducted the clinical control study on 95 patients. The biggest thing which came out of this is that within three days 69 per cent of patients recovered and became negative from positive (cases) and within seven days 100 per cent of them became negative," said Ramdev.
CRONIL KIT CONTAINS
What Regulatory Body Says
- AyushMinistry:- The facts and claims made by Patanjali of the efficacy of its virus medicine, branded ‘Coronil’, were not known to the Ministry of AYUSH, according to a statement by the ministry that governs ayurvedic medicines. It asked Patanjali to stop advertising and publicising claims until the issue is examined.
- ICMR:- Offical statement By ICMR says we don't deal with ayurvedic product hence ICMR do not endorse the Cronil Medicines.
- CDSCO:- Central Drug standard control Organisation is Legal and Govt. authority for approval of new drugs. CDSCO has not approved such medicines.
SARS COV-2 VIRUS Causing CoVID-19. |
My Opinion
- Research
- Preclinical Trials
- Clinical trials Phase 1, Phase II, PhaseIII
- Approval
- Manufacturing
- Post Marketing
- Provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment.
- Site(s)/hospital(s), where the research study was conducted for Covid-19
- Protocol, sample size
- Institutional Ethics Committee clearance
- CTRI registration and results data of the study (ies), and stop advertising/publicising such claims till the issue is duly examined.
- Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuintadvertising such a drug, including an Ayurvedic medicine, is regulated by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and directives issued by the central government pursuant to the virus outbreak.
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuintadvertising such a drug, including an Ayurvedic medicine, is regulated by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and directives issued by the central government pursuant to the virus outbreak.
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuintadvertising such a drug, including an Ayurvedic medicine, is regulated by the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and directives issued by the central government pursuant to the virus outbreak.
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint
Read more at: https://www.bloombergquint.com/business/ayush-ministry-stops-patanjali-from-advertising-purported-covid-medicine
Copyright © BloombergQuint